Experiences with shared decision-making in psychotropic medication for people with intellectual disabilities: perspectives of experts by experience, relatives, and support professionals - Scorecard - MDSpire
Advertisement
Experiences with shared decision-making in psychotropic medication for people with intellectual disabilities: perspectives of experts by experience, relatives, and support professionals
Clinical Scorecard: Perspectives on Shared Decision-Making in Psychotropic Medication for Individuals with Intellectual Disabilities: Insights from Experts by Experience, Family Members, and Support Professionals
At a Glance
Category
Detail
Condition
Intellectual Disabilities
Key Mechanisms
Shared decision-making (SDM) enhances patient involvement and satisfaction in medication choices.
Target Population
Individuals with intellectual disabilities (ID) and their support networks.
Care Setting
Mental healthcare and support services.
Key Highlights
Barriers to SDM include communication challenges and insufficient professional support.
Patients and carers desire more involvement in medication decisions.
Relational dynamics and communication quality significantly influence SDM.
Meaningful involvement requires tailored information and collaboration with relatives.
Psychotropic medications are often prescribed off-label, raising concerns about overmedication.
Guideline-Based Recommendations
Diagnosis
Assess the appropriateness of psychotropic medication prescriptions in individuals with ID.
Management
Implement shared decision-making practices to involve patients and carers in treatment choices.
Monitoring & Follow-up
Regularly evaluate the impact of prescribed medications on the quality of life of individuals with ID.
Risks
Be aware of the risks of overmedication and its effects on daily functioning.
Patient & Prescribing Data
Individuals with intellectual disabilities receiving psychotropic medications.
Psychotropic medications are often prescribed without formal psychiatric diagnoses, primarily to manage challenging behaviors.
Clinical Best Practices
Ensure accessible and understandable information is provided to patients and their families.
Foster collaboration between healthcare professionals, patients, and support networks.
Tailor decision-making processes to accommodate the unique needs of individuals with ID.
